673 related articles for article (PubMed ID: 25649157)
21. Electroretinographic abnormalities in Alport syndrome with a novel COL4A5 truncated variant (p.Try20GlyfsTer19).
Mizobuchi K; Hayashi T; Ohira R; Nakano T
Doc Ophthalmol; 2023 Jun; 146(3):281-291. PubMed ID: 37162688
[TBL] [Abstract][Full Text] [Related]
22. Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group.
Kashtan CE; Ding J; Garosi G; Heidet L; Massella L; Nakanishi K; Nozu K; Renieri A; Rheault M; Wang F; Gross O
Kidney Int; 2018 May; 93(5):1045-1051. PubMed ID: 29551517
[TBL] [Abstract][Full Text] [Related]
23. [Anterior lenticonus: diagnostic aid in Alport syndrome].
Blaise P; Delanaye P; Martalo O; Pierard GE; Rorive G; Galand A
J Fr Ophtalmol; 2003 Dec; 26(10):1075-82. PubMed ID: 14691404
[TBL] [Abstract][Full Text] [Related]
24. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
[TBL] [Abstract][Full Text] [Related]
25. Alport Syndrome: Achieving Early Diagnosis and Treatment.
Kashtan CE
Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
[TBL] [Abstract][Full Text] [Related]
26. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.
Cervera-Acedo C; Coloma A; Huarte-Loza E; Sierra-Carpio M; Domínguez-Garrido E
BMC Nephrol; 2017 Oct; 18(1):325. PubMed ID: 29089023
[TBL] [Abstract][Full Text] [Related]
27. [Alport syndrome or progressive hereditary nephritis with hearing loss].
Gubler MC; Heidet L; Antignac C
Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
[TBL] [Abstract][Full Text] [Related]
28. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
[TBL] [Abstract][Full Text] [Related]
29. [From Alport syndrome to benign familial hematuria: clinical and genetic aspect].
Maziers N; Dahan K; Pirson Y
Nephrol Ther; 2005 May; 1(2):90-100. PubMed ID: 16895672
[TBL] [Abstract][Full Text] [Related]
30. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
[TBL] [Abstract][Full Text] [Related]
31. A female with X-linked Alport syndrome and compound heterozygous COL4A5 mutations.
Mohammad M; Nanra R; Colville D; Trevillian P; Wang Y; Storey H; Flinter F; Savige J
Pediatr Nephrol; 2014 Mar; 29(3):481-5. PubMed ID: 24337245
[TBL] [Abstract][Full Text] [Related]
32. Endothelial cell-specific collagen type IV-α
Funk SD; Bayer RH; Miner JH
Am J Physiol Renal Physiol; 2019 May; 316(5):F830-F837. PubMed ID: 30724107
[TBL] [Abstract][Full Text] [Related]
33. Renal, auricular, and ocular outcomes of Alport syndrome and their current management.
Zhang Y; Ding J
Pediatr Nephrol; 2018 Aug; 33(8):1309-1316. PubMed ID: 28864840
[TBL] [Abstract][Full Text] [Related]
34. A review of clinical characteristics and genetic backgrounds in Alport syndrome.
Nozu K; Nakanishi K; Abe Y; Udagawa T; Okada S; Okamoto T; Kaito H; Kanemoto K; Kobayashi A; Tanaka E; Tanaka K; Hama T; Fujimaru R; Miwa S; Yamamura T; Yamamura N; Horinouchi T; Minamikawa S; Nagata M; Iijima K
Clin Exp Nephrol; 2019 Feb; 23(2):158-168. PubMed ID: 30128941
[TBL] [Abstract][Full Text] [Related]
35. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
36. A new mutation in the COL4A3 gene responsible for autosomal dominant Alport syndrome, which only generates hearing loss in some carriers.
Rosado C; Bueno E; Fraile P; García-Cosmes P; González-Sarmiento R
Eur J Med Genet; 2015 Jan; 58(1):35-8. PubMed ID: 25450602
[TBL] [Abstract][Full Text] [Related]
37. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A
Kidney Int; 2004 May; 65(5):1598-603. PubMed ID: 15086897
[TBL] [Abstract][Full Text] [Related]
38. Ocular manifestations of autosomal recessive Alport syndrome.
Colville D; Savige J; Morfis M; Ellis J; Kerr P; Agar J; Fasset R
Ophthalmic Genet; 1997 Sep; 18(3):119-28. PubMed ID: 9361309
[TBL] [Abstract][Full Text] [Related]
39. [A new case of giant macular hole in a patient with Alport syndrome].
Mercé E; Korobelnik JF; Delyfer MN; Rougier MB
J Fr Ophtalmol; 2012 Oct; 35(8):573-9. PubMed ID: 22695059
[TBL] [Abstract][Full Text] [Related]
40. Maculopathy, Fundus Changes and Anterior Lenticonus in Alport Syndrome.
Ratkovic M; Pidro A; Pidro A
Beyoglu Eye J; 2021; 6(1):66-69. PubMed ID: 35005495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
